{'fraction_non_alphanumeric': 0.022170361726954493, 'fraction_numerical': 0.005834305717619603, 'mean_word_length': 5.549618320610687, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[The endovascular laser therapy of primary glaucoma].

Intravascular irradiation of the blood with He-Ne laser at a wavelength 680 nm and 0.5 mWt power via Leukocyte light-guide introduced into one of the cubital veins was used in the treatment of patients with primary glaucoma. Treatment efficacy was assessed from changes in vision acuity, visual field, angioscotomas, blind spot, ophthalmic tone, and tonographic parameters. Treatment efficacies of traditional therapy and the suggested exposure were compared. Endovascular laser therapy exerted a more marked effect as regarded improvement of vision acuity, decrease of the blind spot and angioscotomas, reduction of intraocular pressure, and improvement of tonographic parameters. This recommends such exposure for the treatment of primary glaucoma patients in complex with other treatment modalities.